&Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4M | Buy |
10,224
+2,165
| +27% | +$848K | 0.03% | 428 |
|
|
2025
Q1 | $3.48M | Buy |
8,059
+1,906
| +31% | +$823K | 0.04% | 382 |
|
|
2024
Q4 | $2.28M | Sell |
6,153
-115
| -2% | -$42.6K | 0.03% | 458 |
|
|
2024
Q3 | $3.26M | Buy |
6,268
+2,488
| +66% | +$1.29M | 0.06% | 272 |
|
|
2024
Q2 | $2.05M | Buy |
3,780
+2,591
| +218% | +$1.4M | 0.09% | 211 |
|
|
2024
Q1 | $617K | Buy |
1,189
+661
| +125% | +$343K | 0.09% | 230 |
|
|
2023
Q4 | $249K | Sell |
528
-48
| -8% | -$22.7K | 0.06% | 240 |
|
|
2023
Q3 | $251K | Hold |
576
| – | – | 0.12% | 141 |
|
|
2023
Q2 | $256K | Buy |
576
+57
| +11% | +$25.3K | 0.11% | 145 |
|
|
2023
Q1 | $238K | Buy |
519
+1
| +0.2% | +$459 | 0.11% | 143 |
|
|
2022
Q4 | $266K | Buy |
518
+469
| +957% | +$241K | 0.13% | 137 |
|
|
2022
Q3 | $254K | Buy |
+49
| New | +$254K | 0.15% | 136 |
|